Medical Services

Neonatal thrombocytopenia is a hematological condition characterized by a platelet count below 150,000/µL in newborns. It is relatively common in neonatal intensive care settings and may present within the first 72 hours (early-onset) or later (late-onset). The condition ranges from mild and self-limiting to severe forms associated with significant bleeding risks.

Causes differ based on timing. Early-onset thrombocytopenia is often linked to placental insufficiency, maternal hypertension, intrauterine growth restriction, or perinatal hypoxia. Late-onset cases are frequently associated with sepsis, necrotizing enterocolitis, or viral infections. Immune-mediated conditions such as neonatal alloimmune thrombocytopenia (NAIT) and maternal autoimmune disorders can also lead to severe platelet destruction.

Clinical manifestations vary and may include petechiae, purpura, bruising, or, in severe cases, internal bleeding such as intracranial hemorrhage. However, many neonates remain asymptomatic and are diagnosed through routine blood tests.

Diagnosis involves complete blood count, peripheral smear examination, and evaluation for underlying causes. Management depends on severity and etiology. Mild cases may only require observation, while severe thrombocytopenia may necessitate platelet transfusions, immunoglobulin therapy, or treatment of underlying conditions.

Prompt identification and tailored management are essential to reduce morbidity and prevent life-threatening complications in affected newborns.